The Discounted Cash Flow (DCF) valuation of Zenas Biopharma Inc (ZBIO) is (121.23) USD. With the latest stock price at 12.35 USD, the upside of Zenas Biopharma Inc based on DCF is -1081.7%.
Based on the latest price of 12.35 USD and our DCF valuation, Zenas Biopharma Inc (ZBIO) is a sell. selling ZBIO stocks now will result in a potential gain of 1081.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.4% - 7.9% | 7.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (263.41) - (79.82) | (121.23) |
| Upside | -2232.9% - -746.3% | -1081.7% |